ivind Enger

1

Commercial ideas from science

• Øivind Enger
• Sarsia Innovation AS

2
(No Transcript)
3
Pharma - origin
4
Is this an invention?
Is this an invention?
5
What about this?
6
(No Transcript)
7
Discovery vs. Invention

• Discovery
• New property of previously known material or
  organism.
• New organism or material from nature
• Invention
• A method for commercial exploitation of the
  discovered organism or property may be an
  invention

8
Discovery vs. Invention

• Discovery (not patentable)
• Observing that something, not previously known
  exists in nature
• Invention (patentable)
• Isolated/adapted/modified materials from nature
  in the purpose of solving a technical problem.

9
Optimal case

• Basic science
• IPR easy to identify
• Patentable!!
• Easy to convert into product
• Established industry
• Inventors have network with relevant industry
• Inventors able/willing to take part in commercial
  development

10
Basic science

• Most opportunities
• Novelty implicit in invention
• All other groups in field often known to inventor

11
IPR

• Few inventors
• Co-autors are not always (in fact almost never..)
  co-inventors
• No gifts or forgotten MTAs

12
Patentable

• Non-obvious (in a patentish meaning)
• No publications
• No seminars/presentations given
• No need to publish like next week......

13
Product(s) easy recognisable

• Easy to see outline of potential product(s)
• Solves a known problem

14
(No Transcript)
15
Established industry

• Invention fits into established industry
• Mass-market achievable
• Invention has a potential to alter esablished
  market structure

16
Committed inventor

• Inventor engagement crucial in all phases of
  commercialisation!
• Inventor network in industry important
• Inventor participation if company is established

17
Inventor